| Literature DB >> 33573555 |
Dineshi Sewvandi Thalakiriyawa1, Primali Rukmal Jayasooriya1, Waruna Lakmal Dissanayaka2.
Abstract
Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into diverse cell lineages. MSC based therapy has become a widely experimented treatment strategy in regenerative medicine with promising outcomes. Recent reports suggest that much of the therapeutic effects of MSCs are mediated by their secretome that is expressed through extracellular vesicles (EVs). EVs are lipid bilayer bound components that carry cellular proteins, mRNA, lncRNAs, and other molecules in order to mediate intercellular communication and signaling. In fact, MSC-derived EVs have been observed to implement the same therapeutic effects as MSCs with minimal adverse effects and could be used as an alternative treatment method to MSC-based therapy. The regenerative activity of MSC-EVs has been observed in relation to multiple cell/tissue lineages using various animal models. However, further research and clinical trials are essential for the advancement of this novel treatment strategy. This review provides an insight into the available literature on applications of MSC-EVs in relation to angiogenesis, neurogenesis, hepatic and kidney regeneration, and wound healing. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Extracellular vesicles; mesenchymal stem cells; paracrine signaling; regeneration.; regenerative medicine; secretome
Mesh:
Year: 2022 PMID: 33573555 DOI: 10.2174/1566524021666210211114453
Source DB: PubMed Journal: Curr Mol Med ISSN: 1566-5240 Impact factor: 2.222